Boxer Capital Management, LLC Quant / Systematic

CIK: 0002018299 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value ($000): $313,727 (100.0% shares, 0.0% debt)

Holdings (34)

TNGX TANGO THERAPEUTICS INC 26.2%

Value ($000) $82,080 Shares 9,771,485 Est. Cost $4.64 Unrealized +45.8%

QURE UNIQURE NV 14.9%

Value ($000) $46,696 Shares 800,000 Est. Cost $9.43 Unrealized +92.5%

RVMD REVOLUTION MEDICINES INC 6.0%

Value ($000) $18,680 Shares 400,000 Est. Cost $50.47 Unrealized -22.4%

KYMR KYMERA THERAPEUTICS INC 5.8%

Value ($000) $18,061 Shares 319,100 Est. Cost $42.51 Unrealized +6.1%

KOD KODIAK SCIENCES INC 3.9%

Value ($000) $12,278 Shares 750,000 Est. Cost $5.74 Unrealized +50.2%

PTCT PTC THERAPEUTICS INC 3.9%

Value ($000) $12,274 Shares 200,000 Est. Cost $52.09 Unrealized 0.0%

AMLX AMYLYX PHARMACEUTICALS INC 3.9%

Value ($000) $12,231 Shares 900,000 Est. Cost $4.71 Unrealized +100.0%

URGN UROGEN PHARMA LTD 3.7%

Value ($000) $11,471 Shares 575,000 Est. Cost $9.60 Unrealized +87.1%

— MERUS N V 3.6%

Value ($000) $11,298 Shares 120,000 Est. Cost $42.05 Unrealized —

CYTK CYTOKINETICS INC 3.5%

Value ($000) $10,992 Shares 200,000 Est. Cost $41.20 Unrealized 0.0%

ABVX ABIVAX SA 3.2%

Value ($000) $10,188 Shares 120,000 Est. Cost $84.90 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 2.3%

Value ($000) $7,307 Shares 110,000 Est. Cost $52.01 Unrealized +9.3%

NKTR NEKTAR THERAPEUTICS 2.3%

Value ($000) $7,113 Shares 125,000 Est. Cost $11.24 Unrealized +194.6%

CBIO CRESCENT BIOPHARMA INC. 1.7%

Value ($000) $5,394 Shares 453,686 Est. Cost $21.15 Unrealized -37.3%

INO INOVIO PHARMACEUTICALS INC 1.7%

Value ($000) $5,382 Shares 2,300,000 Est. Cost $1.91 Unrealized 0.0%

SRPT SAREPTA THERAPEUTICS INC 1.5%

Value ($000) $4,818 Shares 250,000 Est. Cost $20.31 Unrealized -12.2%

— CIDARA THERAPEUTICS INC 1.5%

Value ($000) $4,596 Shares 48,000 Est. Cost $48.71 Unrealized —

CELC CELCUITY INC 1.4%

Value ($000) $4,446 Shares 90,000 Est. Cost $40.03 Unrealized 0.0%

REPL REPLIMUNE GROUP INC 1.4%

Value ($000) $4,400 Shares 1,050,000 Est. Cost $11.51 Unrealized -44.5%

SLDB SOLID BIOSCIENCES INC 1.2%

Value ($000) $3,702 Shares 600,000 Est. Cost $5.85 Unrealized 0.0%

DNLI DENALI THERAPEUTICS INC 1.2%

Value ($000) $3,630 Shares 250,000 Est. Cost $14.37 Unrealized 0.0%

PGEN PRECIGEN INC 0.9%

Value ($000) $2,797 Shares 850,000 Est. Cost $2.82 Unrealized 0.0%

APGE APOGEE THERAPEUTICS INC 0.6%

Value ($000) $1,987 Shares 50,000 Est. Cost $38.18 Unrealized 0.0%

— MIND MEDICINE MINDMED INC 0.6%

Value ($000) $1,928 Shares 163,500 Est. Cost $11.79 Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.6%

Value ($000) $1,793 Shares 250,000 Est. Cost $52.12 Unrealized 0.0%

NRIX NURIX THERAPEUTICS INC 0.5%

Value ($000) $1,617 Shares 175,000 Est. Cost $22.92 Unrealized -54.7%

AVTX AVALO THERAPEUTICS INC 0.5%

Value ($000) $1,589 Shares 125,000 Est. Cost $8.60 Unrealized 0.0%

MIST MILESTONE PHARMACEUTICALS IN 0.4%

Value ($000) $1,333 Shares 666,666 Est. Cost $1.76 Unrealized 0.0%

PEPG PEPGEN INC 0.4%

Value ($000) $1,155 Shares 250,000 Est. Cost $1.61 Unrealized 0.0%

LBRX LB PHARMACEUTICALS INC 0.4%

Value ($000) $1,105 Shares 70,000 Est. Cost $15.87 Unrealized 0.0%

TIL INSTIL BIO INC 0.3%

Value ($000) $1,084 Shares 60,700 Est. Cost $30.49 Unrealized -16.8%

KALV KALVISTA PHARMACEUTICALS INC 0.1%

Value ($000) $248 Shares 20,400 Est. Cost $12.23 Unrealized +13.0%

— NUVATION BIO INC 0.0%

Value ($000) $54 Shares 266,666 Est. Cost $0.23 Unrealized —

SRZNW SURROZEN INC 0.0%

Value ($000) $1 Shares 66,666 Est. Cost $0.02 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
TNGX	TANGO THERAPEUTICS INC	9,771,485	$82,080	26.2%	$4.64	+45.8%	COM	87583X109
QURE	UNIQURE NV	800,000	$46,696	14.9%	$9.43	+92.5%	SHS	N90064101
RVMD	REVOLUTION MEDICINES INC	400,000	$18,680	6.0%	$50.47	-22.4%	COM	76155X100
KYMR	KYMERA THERAPEUTICS INC	319,100	$18,061	5.8%	$42.51	+6.1%	COM	501575104
KOD	KODIAK SCIENCES INC	750,000	$12,278	3.9%	$5.74	+50.2%	COM	50015M109
PTCT	PTC THERAPEUTICS INC	200,000	$12,274	3.9%	$52.09	0.0%	COM	69366J200
AMLX	AMYLYX PHARMACEUTICALS INC	900,000	$12,231	3.9%	$4.71	+100.0%	COM	03237H101
URGN	UROGEN PHARMA LTD	575,000	$11,471	3.7%	$9.60	+87.1%	COM	M96088105
—	MERUS N V	120,000	$11,298	3.6%	$42.05	—	COM	N5749R100
CYTK	CYTOKINETICS INC	200,000	$10,992	3.5%	$41.20	0.0%	COM NEW	23282W605
ABVX	ABIVAX SA	120,000	$10,188	3.2%	$84.90	—	SPONSORED ADS	00370M103
PTGX	PROTAGONIST THERAPEUTICS INC	110,000	$7,307	2.3%	$52.01	+9.3%	COM	74366E102
NKTR	NEKTAR THERAPEUTICS	125,000	$7,113	2.3%	$11.24	+194.6%	COM NEW	640268306
CBIO	CRESCENT BIOPHARMA INC.	453,686	$5,394	1.7%	$21.15	-37.3%	COM	G2545C104
INO	INOVIO PHARMACEUTICALS INC	2,300,000	$5,382	1.7%	$1.91	0.0%	COM SHS	45773H409
SRPT	SAREPTA THERAPEUTICS INC	250,000	$4,818	1.5%	$20.31	-12.2%	COM	803607100
—	CIDARA THERAPEUTICS INC	48,000	$4,596	1.5%	$48.71	—	COM NEW	171757206
CELC	CELCUITY INC	90,000	$4,446	1.4%	$40.03	0.0%	COM	15102K100
REPL	REPLIMUNE GROUP INC	1,050,000	$4,400	1.4%	$11.51	-44.5%	COM	76029N106
SLDB	SOLID BIOSCIENCES INC	600,000	$3,702	1.2%	$5.85	0.0%	COM NEW	83422E204
DNLI	DENALI THERAPEUTICS INC	250,000	$3,630	1.2%	$14.37	0.0%	COM	24823R105
PGEN	PRECIGEN INC	850,000	$2,797	0.9%	$2.82	0.0%	COM	74017N105
APGE	APOGEE THERAPEUTICS INC	50,000	$1,987	0.6%	$38.18	0.0%	COM	03770N101
—	MIND MEDICINE MINDMED INC	163,500	$1,928	0.6%	$11.79	—	COM NEW	60255C885
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	250,000	$1,793	0.6%	$52.12	0.0%	CLASS A ORD	61559X104
NRIX	NURIX THERAPEUTICS INC	175,000	$1,617	0.5%	$22.92	-54.7%	COM	67080M103
AVTX	AVALO THERAPEUTICS INC	125,000	$1,589	0.5%	$8.60	0.0%	COM NEW	05338F306
MIST	MILESTONE PHARMACEUTICALS IN	666,666	$1,333	0.4%	$1.76	0.0%	COM	59935V107
PEPG	PEPGEN INC	250,000	$1,155	0.4%	$1.61	0.0%	COM	713317105
LBRX	LB PHARMACEUTICALS INC	70,000	$1,105	0.4%	$15.87	0.0%	COM SHS	50180M108
TIL	INSTIL BIO INC	60,700	$1,084	0.3%	$30.49	-16.8%	COM NEW	45783C200
KALV	KALVISTA PHARMACEUTICALS INC	20,400	$248	0.1%	$12.23	+13.0%	COM	483497103
—	NUVATION BIO INC	266,666	$54	0.0%	$0.23	—	*W EXP 02/10/202	67080N119
SRZNW	SURROZEN INC	66,666	$1	0.0%	$0.02	—	*W EXP 08/01/203	86889P117